Chart calendar Intellia Therapeutics, Inc.

63f6.Y6WFSRP44WuPYNPO1I0blcXN75CPxqGYVwVpQi8K7Pk.UsrQJkLVlinCJYCWu-RLp663gajloJC1GjA2JWtQ3NQC9vwRS52tIc0QuA~1cb7cfa5ba243ab9e2f30ff5d339651c

Upcoming events on Intellia Therapeutics, Inc.

No events available

Past events on Intellia Therapeutics, Inc.

2026-02-26

Earnings presentation

 08:00 am
2025-11-06

Earnings presentation

 06:00 pm
2025-10-27

Information meeting

 08:30 am
2025-08-07

Earnings presentation

 08:00 am
2025-06-11

Présentation aux Actionnaires / Analystes

 09:00 am
2025-06-11

Annual General Meeting

 09:00 am
2025-05-08

Earnings presentation

 08:00 am

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
36,3
50,0
-27.51%
57,9
52,1
11.08%
67,7
57,1
18.53%

59,5


240


594

EBITDA
Million USD
Released
Forecast
Spread
-506
-482
-5%
-524
-540
3%
-431
-435
0.85%

-446


-420


-392

EBIT
Million USD
Released
Forecast
Spread
-515
-511
-0.9%
-534
-549
2.68%
-441
-455
3%

-452


-412


-330

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-481
-478
-0.72%
-519
-528
1.65%
-413
-428
3.6%

-436


-407


-339

Net income
Million USD
Released
Forecast
Spread
-481
-475
-1.24%
-519
-528
1.67%
-413
-426
3.22%

-436


-400


-332

EPS
USD
Released
Forecast
Spread
-5,42
-5,40
-0.44%
-5,25
-5,37
2.24%
-3,81
-3,99
4.54%

-3,56


-2,00


-0,74

Announcement Date22/02/2427/02/2526/02/26-

Quarterly results

Fiscal PeriodDecember 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
6,96
18,3
-61.93%
9,11
7,17
27.06%
12,9
8,10
58.94%
16,6
12,0
38.72%
14,2
12,2
17.12%
13,8
14,1
-2.42%
23,0
12,2
89.08%

13,6


13,1


13,5


17,2


10,8


14,7


25,7


34,5

EBITDA
Million USD
Released
Forecast
Spread






-134
-152
11.63%









-96,3
-117
17.64%

-111


-117


-119


-118













EBIT
Million USD
Released
Forecast
Spread
-139
-127
-9.37%
-145
-143
-0.93%
-136
-148
7.57%
-121
-137
11.51%
-110
-111
1.25%
-111
-110
-1.24%
-98,7
-114
13.58%

-113


-115


-119


-121


-116


-113


-103


-94,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-147
-120
-22.16%
-136
-136
0.48%
-129
-136
5.18%
-114
-129
11.41%
-101
-102
0.79%
-101
-102
1.05%
-95,8
-107
10.19%

-107


-109


-114


-117


-112


-110


-99,5


-91,2

Net income
Million USD
Released
Forecast
Spread
-147
-119
-23.46%
-136
-136
0.33%
-129
-136
5.42%
-114
-130
11.77%
-101
-103
2.15%
-101
-103
1.52%
-95,8
-107
10.07%

-106


-109


-114


-117


-112


-110


-99,5


-91,2

EPS
USD
Released
Forecast
Spread
-1,52
-1,23
-23.93%
-1,34
-1,39
3.26%
-1,27
-1,33
4.79%
-1,10
-1,27
13.65%
-0,98
-1,00
2.14%
-0,92
-0,98
5.76%
-0,83
-0,95
12.81%

-0,90


-0,90


-0,92


-0,89


-0,91


-0,81


-0,72


-0,70

Announcement Date08/08/2407/11/2427/02/2508/05/2507/08/2506/11/2526/02/26--------
2026-04-15

Earnings presentation

 09:00 pm
2026-04-17

Earnings presentation

 03:00 am
2026-04-18

Earnings release - Q1 2026

~ 03:00 am
2026-04-21

Earnings release - Annual 2025

~ 03:00 am
2026-04-22

Earnings release - Q1 2026

~ 04:00 pm
2026-04-22

Analyst/Investor Day

 10:00 am
2026-04-22

Information meeting

 07:00 am
2026-04-22

Annual General Meeting

Day
2026-04-23

Earnings presentation

 09:00 am
2026-04-23

Annual General Meeting

 10:30 am

Past sector events for Intellia Therapeutics, Inc.

Today

Earnings release - Annual 2025

~ 12:30 pm
Today

Annual General Meeting

 08:00 am
2026-04-14

Earnings release - Annual 2025

~ 03:00 am
2026-04-13

Information meeting

 08:00 am
2026-04-13

Information meeting

 02:00 pm
2026-04-08

Earnings presentation

 04:00 am
2026-04-08

Information meeting

 08:00 am
2026-04-08

Earnings presentation

 08:00 am
2026-04-07

Information meeting

Day
2026-04-02

Information meeting

 08:00 am

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NTLA Stock
  4. Calendar Intellia Therapeutics, Inc.